Save the date for the Florida Society of Pathologists Summer Pathology Conference taking place July 12-14 at the Ritz-Carlton Hotel in Fort Lauderdale, Florida.
The conference will feature innovative topics in pathology and interesting case presentations related to topics featured throughout the conference.
In addition to the educational offerings, attendees will have an opportunity to connect with colleagues and interact with industry leaders in the field of pathology during exhibit hall social functions.
Make plans to arrive on Friday, July 12 in the afternoon to check in early and enjoy the hotel at your leisure before the conference kicks off on Saturday, July 13
|Abstract Poster Submission #1|
|Disclosure of Funding Support|
|Choose one of the following Topics|
Richard R. Gammon, MD
Topic: Blood Banking
Dina R. Mody, MD
Medical Director, Cytopathology
Department of Pathology and Genomic Medicine
The Ibrahim Ramzy chair in Pathology
Houston Methodist Hospital
Professor of Pathology and Laboratory Medicine
Weill College Medicine
Topic: Cytology in conjunction with surgical pathology
Mehrdad Nadji, MD
Professor and Vice Chair
Department of Pathology
University of Miami Miller School of Medicine
Topic: IHC and Molecular Biomarkers
Rish K. Pai, MD, PhD
Professor of Laboratory Medicine and Pathology
Topic: Gastrointestinal Pathology and Medical Liver
Artur E. Rangel Filho, MD, PhD
Medical Director, Clinical and Molecular Pathology
Memorial Healthcare System
Pathology Consultants of South Broward
Topic: Basics of Molecular Diagnostics for the Everyday Practicing Pathologist
The Ritz Carlton Fort Lauderdale is a premier beachfront location offering guests remarkable amenities including an infinity pool overlooking the ocean; direct access to the beach with towel and chair service, a luxurious 8,500 square foot spa, and state of the art room accommodations all equipped with balconies to admire the views of Fort Lauderdale. From discovering the boutiques of Las Olas Boulevard to exploring the canals of the Florida Intracoastal Waterway, Fort Lauderdale is a destination that will surprise and delight travelers.
The FSP has a special discounted room rate of $199/night plus a $20/night resort fee. The group rate is available until June 17, 2019 or until the room block is filled. We recommend that you make your reservation early, the room block will sell out.
The following amenities and services are included in the resort fee:
Registration will open on Friday, July 12 from 3:00–6:00 PM. Breakfast will be provided on Saturday, July 13 in the exhibit hall at 7:00 AM, and the ﬁrst session will begin at 8:00 AM. Book your hotel for Friday, July 12 to take full advantage of the FSP Summer Anatomic Pathology Conference.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Florida Medical Association and the Florida Society of Pathologists. The Florida Medical Association is accredited by the ACCME to provide continuing medical education for physicians.
The Florida Medical Association designates this live activity for a maximum of 10.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CRITERIA FOR SUCCESS
Statements of credit/participation will be awarded based on the participant’s attendance at each session and submission of the activity evaluation form. A statement of credit will be available upon completion of an online evaluation/claimed credit form at www.flpath.org/claimcme. If you have questions about this CME/CE activity, please contact the FSP at 904-309-6261. Credit must be claimed by July 24, 2019.
This activity is designed to meet the needs of practicing physicians, pathologists, and other specialists involved with pathology.
STATEMENT OF NEED
The field of pathology is constantly changing, and many of the most important advances in the field. In the setting of new technology, techniques and advancements in the field, practice gaps are inevitable. As such, pathologists require ongoing educational opportunities to stay current in order to maintain and improve their knowledge and competence in the field.
At the conclusion of this activity, all participants should be able to:
At the time of this printing, full commercial support information was not available. All commercial support will be provided to attendees in advance of the meeting.
The planners of this activity disclosed no financial relationships relevant to the content to be presented with the exception of Qihui (Jim) Zhai, MD who disclosed that he received Grant/Research Support from Springer, LLW and as a member of the Speaker’s Bureau for USCAP, CAP.
The speakers for this activity disclosed no financial relationships with commercial interests whose products or services have a direct bearing on the subject matter of these presentations.
We invite you to participate as a sponsor and exhibitor in the Florida Society of Pathologists Summer Pathology Conference taking place on July 13-14 in Ft. Lauderdale, Florida. Interact and showcase your products and services with approximately 150 pathologists.
We have added some new and exciting sponsorship opportunities and look forward to working wtih you to confirm your participation in our event.
For more information on exhibiting or sponsoring please call 904-309-6204 or email email@example.com
Sponsored Lunch Symposium Details
To reserve your seat for this lunch symposium please email firstname.lastname@example.org
Title of Activity:
The TRK to Tumor-Agnostic Care in Solid Tumors: A Pathology-Focused Guide to the Clinical Role of TRK Fusions in Personalizing Cancer Therapy
Date of Activity:
Saturday, July 13, 2019 at 12:45vPM – 1:45 PM
Anna F. Farago, MD, PhD
Assistant in Medicine
Massachusetts General Hospital
Assistant Professor of Medicine
Harvard Medical School
With the approval of the first ‘tumor agnostic’ strategy directed against NTRK gene fusion positive cancers, there’s an acute need for clinical professionals to understand how best to capture gene fusions and integrate appropriate TRK inhibitors into cancer care. This curriculum will explore how pathologists and oncologists can collaborate to apply precision oncology treatment tools in adult and pediatric patients across a wide range of TRK fusion-positive solid tumors. Experts will discuss the rationale for molecular testing for TRK fusions in a range of cancer settings, including head and neck cancer, GI cancers, breast cancer, and lung cancer, among others, as well as which patients may be candidates for treatment with TRK inhibitors. Other topics will include a guide to selecting and interpreting results of diagnostic testing techniques for confirming the presence of TRK fusions, as well as strategies for using this diagnostic information when making clinical decisions.
Educational Grant supported by:
Bayer and Loxo Oncology
APS Medical Billing is a premier billing company that provides expert billing and practice management solutions to practices nationwide. Some of the services provided include expert ICD-10 and CPT coding, contract management, and comprehensive charge capture systems to ensure its client’s financial success.
Biocartis is an innovative molecular testing company providing next generation solutions aimed to researchers in the oncology field. Biocartis’ proprietary Idylla™ platform is a fully automated sample-to-result, real-time PCR system that offers accurate, highly reliable molecular information from a variety of biological samples in virtually any laboratory setting. Today, Biocartis offers assays for EGFR, KRAS, NRAS, BRAF, and MSI biomarkers and is developing a rapidly expanding menu. Our global headquarters are in Belgium with a U.S. office located in Jersey City, NJ. Globally, we have a presence in 70 countries and there are over 940 Idylla™ systems in place.
Cleveland Clinic Laboratories is dedicated to providing high-quality, clinically impactful pathology and laboratory diagnostic services combined with readily available consultation from experienced pathologists and laboratory scientists.
For more than a century, Merck has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Today, Merck continues be at the forefront of research to deliver innovative health solutions and advance the prevention and treatment of diseases that threaten people and animals around the world.
Neogenomics specializes in cancer genetic testing and information services with the most comprehensive oncology-focused testing menus globally to diagnose and treat cancer. NeoGenomics operates CLIA certified laboratories serving the needs of pathologists, oncologists, academic centers, hospital systems, Pharma, and managed care organizations.
FSP Member Login